Esketamine nasal spray for depression: Mayo Clinic Radio




Dr. Jennifer Vande Voort, a Mayo Clinic psychiatrist, discusses esketamine nasal spray — a fast-acting treatment for depression that recently was approved by the Food and Drug Administration.

To learn more about depression, visit: https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.53693099.2041400379.1554121182-165526356.1480776015

This interview originally aired April 6, 2019.

source

Leave a Reply

Your email address will not be published. Required fields are marked *